# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹456 Cr** Q4 (+6%) · **₹2,897 Cr** FY26 (+9%) * **EBITDA:** **₹-1 Cr** Q4 (+96% improvement) * **PAT:** **₹-15 Cr** Q4 (+52% improvement) * **Segment Revenue (FY26):** **₹2,416 Cr** Crop Care (+8%) · **₹481 Cr** Seeds (+15%) * **B2C Performance:** **₹255 Cr** Q4 (+15%) · **₹1,657 Cr** FY26 (+5%) ## B. Revenue Growth * **Mixed Q4 Drivers:** Quarterly top-line growth was achieved through pricing gains despite a mid-single-digit decline in overall volumes. * **B2C Dynamics:** Annual B2C growth was volume-led, while the current quarter's revenue mix was heavily weighted toward Crop Protection (80%) over Seeds/Plant Health (20%). * **Segment Outperformance:** The Seeds business emerged as a high-growth engine, significantly outpacing the broader Crop Care segment on a full-year basis. ## C. Margins & Profitability * **Loss Narrowing:** Significant year-on-year improvement in EBITDA and PAT reflects better capacity utilization and a **₹3 Cr** exceptional gain from land divestment. * **Margin Divergence:** Consolidated margins benefited from B2B exports and Seeds, whereas standalone B2C margins softened due to inventory liquidation in specific products (Clasto and Benzilla). * **CSM Resilience:** Contractual safeguards in the Contract Solutions Manufacturing (CSM) business provided downside protection, supporting gross margin expansion despite volume fluctuations. * **B2B Recovery:** Management noted improving B2B margins and a strategic focus on navigating "new normal" supply chain disruptions. ## D. Balance Sheet & Cost Structure * **Liquidity & Working Capital:** Maintained a robust cash position of **₹541 Cr** with stable collection cycles, though inventory remains slightly elevated compared to the prior year. * **Inventory Strategy:** Current stockpiles are predominantly composed of low-cost raw materials, positioned as a hedge to protect future margins against volatility. * **Inflationary Pressures:** The business is grappling with substantial input cost inflation, with raw material hikes driving overall cost increases of **15% to 25%**. --- # 2. Operating Segments ## A. Key Figures * **Crop Care Revenue:** **₹425 cr** Q4 (+5%) · **₹255 cr** Domestic B2C Q4 (+15%) * **Seeds Revenue:** **₹31 cr** Q4 (+23%) * **Exports Revenue:** **₹77 cr** Q4 (-33%) * **CSM Revenue:** **₹66 cr** Q4 (+59%) * **Soil & Plant Health Revenue:** **₹47 cr** Q4 (+27%) · **>₹50 cr** Annual ## B. Crop Care * **Domestic B2C Momentum:** Robust double-digit quarterly growth was fueled by a strong volume surge in insecticides, offsetting earlier H1 weakness caused by erratic rainfall. * **Product Performance:** Annual gains were led by herbicides and fungicides, while insecticides saw a marginal full-year decline due to low seasonal usage. * **Supply Chain Resilience:** Management reported stable product availability for the domestic branded portfolio despite ongoing global supply chain volatility. ## C. Seeds Business * **Growth Drivers:** Strong quarterly revenue expansion was powered by significant price hikes in cotton and millets, alongside healthy volume growth. * **Margin Headwinds:** Profitability faces pressure from incremental third-party processing costs and **open-field pad drying** necessitated by simultaneous harvesting and capacity constraints. * **Strategic Product Mix:** Growth is shifting toward rice, maize, and millet where pricing power exists, as government-mandated flat pricing for cotton makes that segment purely volume-driven. * **Innovation Pipeline:** Launching a bundled rice seed offering featuring **Paryan herbicide-tolerant technology**, while maintaining a foundation in **BT technology** for the cotton portfolio. ## D. Exports & CSM * **Divergent B2B Performance:** The CSM vertical saw exceptional growth through both volume and price gains, contrasting sharply with a steep decline in Exports due to lower volumes of Metribuzin and Pendimethalin. * **B2B Scaling:** Total B2B revenue reached **₹759 cr**, benefiting from an expanded customer base and improved realizations. ## E. Soil & Plant Health * **High-Growth Incubation:** The segment outperformed the broader B2C portfolio with significant revenue growth driven by a nearly **30% volume increase** in micronutrients and biofertilizers. * **Investment Outlook:** Following the successful scaling of the business to over **₹50 cr**, management intends to increase investment in this segment to capture further growth potential. * **Operational Model:** Currently utilizes an outsourced incubation model, mirroring the strategy previously used for the aquafeed business. --- # 3. Product & Strategic Initiatives ## A. Portfolio Optimization & Strategy * **Strategic Diversification:** Shifting focus toward herbicides, soil/plant health, and seeds to mitigate volatility inherent in moisture-dependent insecticide and fungicide demand. * **Core Segment Rationalization:** Crop Care is undergoing territory rationalization and cost simplification, while the Seeds segment is narrowing its focus to five core crops (**Cotton, Maize, Millet, Mustard, and Rice**) to achieve scale. * **Pipeline & IP Development:** Secured a patent for **Spiro** (Paddy herbicide) and commercialized **Pencycuron**; the future pipeline is now concentrated on **three new molecules** for release over the next **2-3 years**. * **Asset-Light R&D Approach:** Opting to license GE and herbicide-tolerant technologies from global majors rather than funding intensive in-house research, citing global patent dominance and R&D cost disparities. ## B. Technology & Innovation * **Open Innovation Ecosystem:** Launched the **Idea2Impact** platform in Q4 to source and commercialize external agri-innovations. * **Accelerated Seed R&D:** Utilizing advanced genetic tools to shorten product development cycles while navigating evolving gene-editing (GE) regulations. * **Parallel Development Tracks:** Streamlining time-to-market by conducting manufacturing process establishment and buyer collaborations in parallel with formal registration. ## C. Digital Marketing & Distribution * **Precision Targeting:** Deployed the **Saksham GIS** platform for scientific village identification and **Sampark Plus** to capture real-time farmer demand signals. * **Digital Ecosystem Expansion:** Increasing retailer engagement via the **Anubandh Edge** platform and utilizing digital AV Van campaigns to drive sales conversion. ## D. Growth Opportunities * **Aquafeed Venture:** Entering an experimental phase in the aquafeed market to capitalize on rising animal-protein demand; the segment is currently in an "understanding phase" similar to the soil health business **5-7 years ago**. * **Evaluation Timeline:** Management intends to spend **one more year** (or **1-2 cycles**) evaluating the aqua business's long-term viability before committing to large-scale capital investment. --- # 4. Supply Chain & Manufacturing ## A. Key Figures * **Cost Outlook:** **15% to 25%** projected increase in Kharif season inventory costs * **Procurement Cycle:** **90 to 150 days** lead time for agricultural raw materials ## B. Inventory Management * **Strategic Stockpiling:** Management intentionally limited Q4 placement to preserve low-cost stock for Q1, aiming for higher price realization as market sentiment improves. * **Risk Mitigation:** Inventory days for FY26 trended higher due to a strategic decision to build raw material buffers starting in January to hedge against **geopolitical conflicts**. * **Industry Normalization:** Following a two-year surplus "hangover," industry-wide crop protection inventory has returned to standard levels. * **Kharif Readiness:** Supply for the upcoming season is secured through internal production of **five key ingredients** and daily monitoring protocols reminiscent of COVID-era management. ## C. Procurement & Logistics * **Calibrated Sourcing:** To avoid the risk of high-cost inventory if crude prices soften, the company is limiting procurement strictly to Kharif season requirements. * **Stabilizing Inputs:** Extreme volatility and force majeure notices in raw materials have transitioned to relative normalcy, though **China-linked concentration** and logistics costs remain systemic pressures. * **Cost Pass-Through:** The company intends to pass on anticipated double-digit production cost increases to the market where feasible. ## D. Production Efficiency * **Manufacturing Excellence:** Operational improvements led to record production volumes, with a strategic pivot toward **high-margin biologicals** and next-generation products. * **Operational Continuity:** No manufacturing disruptions are anticipated during the critical May-June window, with coverage extending into the following months. --- # 5. Demand & Pricing Trends ## A. Key Figures * Domestic Formulation Volume: Q4 growth driven by Benzilla and Plasto liquidation * **Summer Sowing Area:** **-4.7%** YoY (Rice **-7.1%**, Oilseeds **-6.1%**, Pulses **+17%**) * **Global Crop Protection Market:** **$70-75 Bn** (Est. 2026) · **5.0-5.5%** (Projected CAGR) ## B. Volume & Pricing * **Aggressive Pricing Strategy:** Rallis is among the first to implement price hikes across its global portfolio to offset rising procurement costs; new supplies are being billed at higher rates while Q1 carryover was cleared at old prices. * **Product Mix Dynamics:** Q4 saw volume growth in Pendimethalin and Hexaconazole, offset by declines in Metribuzin and Acephate; management emphasizes H1/H2 evaluation over quarterly data due to seasonal insecticide/herbicide performance. * **Inventory Resolution:** Approximately **80%** of Benzilla inventory issues are resolved, though domestic volumes were impacted by liquidation and lower chili plantings affecting Plasto. ## C. Farmer Sentiment & Market Consumption * **Anticipated Down-Trading:** Management expects a shift toward branded generics and lower-priced seeds as farmers manage costs; Rallis is strategically positioned to benefit from this "down-trading" trend. * **Kharif Outlook:** Demand remains in "wait-and-watch" mode pending rainfall patterns and commodity prices; a clearer sentiment for the seed market is expected by **late May**. * **Global Market Divergence:** The international environment remains uneven, characterized by supportive US demand but persistent weakness in Brazil and high global inventory levels. ## D. Competitive Position * **Structural Acephate Challenges:** Competitive pressure in the US—where raw material suppliers also act as finished product rivals—has led the company to pivot focus toward the domestic market. * **Cost Pass-Through Viability:** The ability to protect margins depends on monsoon stability in June/July; barring a total monsoon failure, the company expects the market to absorb necessary price increases. * **Crop Economics:** Maize is projected to remain highly competitive for acreage based on per-acre profitability, despite broader fluctuations in agricultural commodity prices. --- # 6. Risks & Agri-Sector Factors ## A. Key Figures * **Monsoon Forecast:** **92% of LPA** (Below-normal) · **8% deficit** vs. Long Period Average * **Climate Impact:** **2.49 lakh hectares** crop damage (Rabi season) * **Input Cost Inflation:** **~25% increase** in Glyphosate prices * **Sector Growth:** **USD 9.6-10.0 billion** projected FY27 market size (+3-4%) ## B. Monsoon & Climate * **Climate Headwinds:** Below-normal rainfall and rising El Niño odds threaten early-season deficits, risking **5-10% demand cuts** for herbicides and insecticides. * **Structural Resilience:** Irrigation now covers **~55% of arable land**, providing a buffer against rainfall volatility; rural income is further stabilized by dairy and poultry (contributing **20-25%** to earnings). * **Regional Outlook:** While specific regions like Marathwada face El Niño risks, major hubs in North and Central India remain resilient; management emphasizes that rainfall distribution is more critical than total volume. ## C. Geopolitical & Supply Chain Disruptions * **Market Shift:** The sector is transitioning to a "seller’s market" as war-induced constraints and Middle East tensions trigger panic buying and hoarding. * **Acreage Shifts:** Potential disruptions in Basmati rice exports due to Middle East instability may lead farmers to pivot toward **regular rice or maize**. * **Normalization Timeline:** High costs are expected to persist through the Kharif season; management estimates a **3 to 4 month** lag for supply chains to stabilize even if geopolitical tensions resolve. ## D. Input Cost Volatility * **Margin Compression:** Significant price hikes in active ingredients (including Glufosinate and CTPR) and rising petrochemical/solvent costs are expected to squeeze downstream margins. * **Energy & Raw Materials:** Precise forecasting remains difficult due to ongoing volatility in energy markets and global supply chain bottlenecks. ## E. Regulatory & Policy Updates * **Fertilizer Dynamics:** The government is currently absorbing price increases; a potential **10% reduction** in urea availability is viewed as manageable due to current over-application by farmers. * **Standardization:** The **FCO 2026 amendment** will modernize biostimulant standards for humic acid and seaweed, likely improving product reliability and regulatory clarity. * **Trade Barriers:** Domestic market dynamics remain influenced by strict government restrictions on the import of **GM maize and soybean**. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth (Seeds):** **Mid-teen to high double-digit** target * **Price Hikes:** **5% to 10%** implemented/planned * **Input Cost Inflation:** **15% to 20%** increase ## B. Revenue & Segment Projections * **Strategic Pricing:** Top-line expansion in Crop Protection is contingent on price hikes to neutralize significant raw material inflation. * **Seeds Portfolio Momentum:** Robust growth expectations for the seed business are underpinned by a mix of volume gains and improved realizations. * **Crop-Specific Outlook:** **Cotton** is identified as the primary growth driver, followed by maize; however, millet acreage remains sensitive to monsoon volatility. * **Export Optimism:** Management maintains a constructive outlook for key molecules, specifically **metribuzin, pendimethalin, and hexaconazole**. ## C. Margin Stability & Risk Factors * **Margin Pressure:** Profitability outlook remains cautious (stable to soft) as the company navigates higher sourcing costs and competitive pricing dynamics. * **Macro Headwinds:** Potential downside risks include a **low monsoon forecast**, which may dampen farmer sentiment and overall purchasing power. * **Commodity Dynamics:** While most crop prices remain firm, **rice** faces headwinds from global excess supply, potentially impacting segment contribution.